SBC SBC Medical Group
SBC Medical Group earnings company data as of 4:48 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 13 Nov | EPS | 0.11 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | 0.12 | — | — |
| Rev | — | $49.0M | — |
Insider trades
Open-market buys and sales by SBC's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $20.2M sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Yoshiyuki Aikawa CEOSale$1.4M 465,000 shares at $3.02 0.6% of stakeTraded Apr 28 Filed Apr 29
-
Yoshiyuki Aikawa CEOSale$9.4M 3,100,000 shares at $3.02 3.8% of stakeTraded Apr 21 Filed Apr 23
-
Yoshiyuki Aikawa CEOSale$9.4M 4,422,900 shares at $2.12 84% of stakeTraded Mar 6 Filed Mar 10
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 3.01,3.03,5.03,5.07,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 10-K/A | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 424B7 | Filing Doc | ||
| 424B7 | Filing Doc | ||
| 8-K | 2.02,7.01,8.01,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.